10 patents currently held
25 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2041. from the record
Of the 25 now held by other companies, 21 name Amneal Complex Products Research LLC as their current owner, and 4 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2041
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Jun 2039 · High confidence
Granted 2020. Computed term ends 2039. A terminal disclaimer caps this term to an earlier patent's.
now held by Amneal Complex Products Research LLC
Also notable
Ends Jun 2038 · Medium confidence
A family of 8 related applications built on the 2022 grant. Protection runs to 2038. A terminal disclaimer caps this term to an earlier patent's.
now held by Amneal Complex Products Research LLC
Also notable
Ends May 2035 · High confidence
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2035.
now held by Amneal Complex Products Research LLC
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
- Oct 5Assignment recorded on 1 record: Narayan, Om and 2 others to Kashiv Biosciences, LLC Recorded Oct 5, 2026, executed Nov 28, 2022. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76610, frame 630.
- 2 of the patents on this record were granted since Aug 19, 2026
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Process of Purification of Protein | 4 in force | to May 2041 |
| An Improved Process of Storing and Preparing the Protein | 1 in force | to Sep 2043 |
| Assay Method of Antibody | 1 in force | to Jun 2043 |
| A Process for Improving Omalizumab Expression in Cho Cells | 1 in force | to Feb 2043 |
| Stable Ready to Dilute Composition of Carfilzomib | 1 in force | to Oct 2042 |
Patents held now
Soonest term end first.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,139,510 | Process of Purification of Protein In force · High confidence | In force | High confidence | |
| US 12,378,282 | Process of Purification of Protein In force · High confidence | In force | High confidence | |
| US 12,435,106 | Process of Purification of Protein In force · Medium confidence | In force | Medium confidence | |
| US 12,600,747 | Process of Purification of Protein In force · Medium confidence | In force | Medium confidence | |
| US 12,767,686 | Separation of Pre-Peak and Post-Peak in Fusion Protein Sample by Using Size Exclusion High Performance Liquid Chromatography In force · High confidence | In force | High confidence | |
| US 12,710,424 | An Extraction Process of Pancrelipase and Evaluation Thereof In force · High confidence | In force | High confidence | |
| US 12,440,534 | Stable Ready to Dilute Composition of Carfilzomib In force · Medium confidence | In force | Medium confidence | |
| US 12,698,345 | A Process for Improving Omalizumab Expression in Cho Cells In force · High confidence | In force | High confidence | |
| US 12,352,759 | Assay Method of Antibody In force · High confidence | In force | High confidence | |
| US 12,760,062 | An Improved Process of Storing and Preparing the Protein In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 25 patents in force now held by others · 1 patent ended · 42 applications pending · 14 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.